Douglas Jolly
2017
In 2017, Douglas Jolly earned a total compensation of $878.1K as Executive Vice President, Research and Pharmaceutical Development at Forte Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $106,751 |
|---|---|
| Option Awards | $503,935 |
| Salary | $266,962 |
| Other | $489 |
| Total | $878,137 |
Jolly received $503.9K in option awards, accounting for 57% of the total pay in 2017.
Jolly also received $106.8K in non-equity incentive plan, $267K in salary and $489 in other compensation.
Rankings
In 2017, Douglas Jolly's compensation ranked 9,596th out of 14,666 executives tracked by ExecPay. In other words, Jolly earned more than 34.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,596 out of 14,666 | 35th |
Division Manufacturing | 3,692 out of 5,772 | 36th |
Major group Chemicals And Allied Products | 1,276 out of 2,075 | 39th |
Industry group Drugs | 1,027 out of 1,731 | 41st |
Industry Pharmaceutical Preparations | 807 out of 1,333 | 40th |
Source: SEC filing on April 19, 2019.
Jolly's colleagues
We found three more compensation records of executives who worked with Douglas Jolly at Forte Biosciences in 2017.